📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer. (2020)

First Author: Lu S

Attributed to: Development of an effective therapeutic regimen for treatment of advanced pancreatic cancer using a novel immunotherapeutic agent funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-19-1395

PubMed Identifier: 31767564

Publication URI: http://europepmc.org/abstract/MED/31767564

Type: Journal Article/Review

Volume: 26

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 2

ISSN: 1078-0432